Distinguishing and predicting drug patents
- PMID: 36922695
- DOI: 10.1038/s41587-023-01703-0
Distinguishing and predicting drug patents
References
-
- Congressional Research Service. Drug Pricing and Pharmaceutical Patenting Practices (11 February 2020); https://sgp.fas.org/crs/misc/R46221.pdf
-
- Letter from Janet Woodcock, Acting Commissioner of FDA to Andrew Hirshfeld, Director of the USPTO (10 September 2021); https://www.fda.gov/media/152086/download
-
- Letter from Katherine Vidal, Director of the USPTO to Robert Califf, Commissioner of FDA (6 July 2022); https://www.uspto.gov/sites/default/files/documents/PTO-FDA-nextsteps-7-...
-
- Request for Comments USPTO Initiatives to Ensure the Robustness and Reliability of Patent Rights, 88 Fed. Reg. 9,492 (14 February 2023).
-
- American Intellectual Property Law Association. 2021 Report of the Economic Survey (September 2021).
MeSH terms
LinkOut - more resources
Full Text Sources